These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 27472901

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
    Ramadoss S, Guo G, Wang CY.
    Oncogene; 2017 Jan 05; 36(1):47-59. PubMed ID: 27270439
    [Abstract] [Full Text] [Related]

  • 3. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
    Wilson S, Fan L, Sahgal N, Qi J, Filipp FV.
    Oncotarget; 2017 May 02; 8(18):30328-30343. PubMed ID: 28416760
    [Abstract] [Full Text] [Related]

  • 4. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
    Ramadoss S, Sen S, Ramachandran I, Roy S, Chaudhuri G, Farias-Eisner R.
    Oncogene; 2017 Mar 02; 36(11):1537-1545. PubMed ID: 27694900
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model.
    Zhao QY, Lei PJ, Zhang X, Zheng JY, Wang HY, Zhao J, Li YM, Ye M, Li L, Wei G, Wu M.
    Clin Epigenetics; 2016 Mar 02; 8():34. PubMed ID: 27034728
    [Abstract] [Full Text] [Related]

  • 7. Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.
    Nakatsuka T, Tateishi K, Kudo Y, Yamamoto K, Nakagawa H, Fujiwara H, Takahashi R, Miyabayashi K, Asaoka Y, Tanaka Y, Ijichi H, Hirata Y, Otsuka M, Kato M, Sakai J, Tachibana M, Aburatani H, Shinkai Y, Koike K.
    Oncogene; 2017 Nov 09; 36(45):6262-6271. PubMed ID: 28692045
    [Abstract] [Full Text] [Related]

  • 8. The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.
    Cho HS, Toyokawa G, Daigo Y, Hayami S, Masuda K, Ikawa N, Yamane Y, Maejima K, Tsunoda T, Field HI, Kelly JD, Neal DE, Ponder BA, Maehara Y, Nakamura Y, Hamamoto R.
    Int J Cancer; 2012 Aug 01; 131(3):E179-89. PubMed ID: 22020899
    [Abstract] [Full Text] [Related]

  • 9. Histone Demethylase KDM3 (JMJD1) in Transcriptional Regulation and Cancer Progression.
    Fan L, Sudeep K, Qi J.
    Adv Exp Med Biol; 2023 Aug 01; 1433():69-86. PubMed ID: 37751136
    [Abstract] [Full Text] [Related]

  • 10. The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.
    Wade MA, Jones D, Wilson L, Stockley J, Coffey K, Robson CN, Gaughan L.
    Nucleic Acids Res; 2015 Jan 01; 43(1):196-207. PubMed ID: 25488809
    [Abstract] [Full Text] [Related]

  • 11. KDM3A-mediated demethylation of histone H3 lysine 9 facilitates the chromatin binding of Neurog2 during neurogenesis.
    Lin H, Zhu X, Chen G, Song L, Gao L, Khand AA, Chen Y, Lin G, Tao Q.
    Development; 2017 Oct 15; 144(20):3674-3685. PubMed ID: 29042477
    [Abstract] [Full Text] [Related]

  • 12. The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis.
    Sechler M, Parrish JK, Birks DK, Jedlicka P.
    Oncogene; 2017 Jul 20; 36(29):4150-4160. PubMed ID: 28319067
    [Abstract] [Full Text] [Related]

  • 13. The Histone H3K27me3 Demethylases KDM6A/B Resist Anoikis and Transcriptionally Regulate Stemness-Related Genes.
    Shait Mohammed MR, Zamzami M, Choudhry H, Ahmed F, Ateeq B, Khan MI.
    Front Cell Dev Biol; 2022 Jul 20; 10():780176. PubMed ID: 35186918
    [Abstract] [Full Text] [Related]

  • 14. Knockout of KDM3A in MDA-MB-231 breast cancer cells inhibits tumor malignancy and promotes apoptosis.
    Han Y, Maimaiti N, Sun Y, Yao J.
    J Mol Histol; 2024 Feb 20; 55(1):139-148. PubMed ID: 38165573
    [Abstract] [Full Text] [Related]

  • 15. The KDM3A-KLF2-IRF4 axis maintains myeloma cell survival.
    Ohguchi H, Hideshima T, Bhasin MK, Gorgun GT, Santo L, Cea M, Samur MK, Mimura N, Suzuki R, Tai YT, Carrasco RD, Raje N, Richardson PG, Munshi NC, Harigae H, Sanda T, Sakai J, Anderson KC.
    Nat Commun; 2016 Jan 05; 7():10258. PubMed ID: 26728187
    [Abstract] [Full Text] [Related]

  • 16. G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression.
    Collins NL, Reginato MJ, Paulus JK, Sgroi DC, Labaer J, Brugge JS.
    Mol Cell Biol; 2005 Jun 05; 25(12):5282-91. PubMed ID: 15923641
    [Abstract] [Full Text] [Related]

  • 17. Specific phosphorylation of histone demethylase KDM3A determines target gene expression in response to heat shock.
    Cheng MB, Zhang Y, Cao CY, Zhang WL, Zhang Y, Shen YF.
    PLoS Biol; 2014 Dec 05; 12(12):e1002026. PubMed ID: 25535969
    [Abstract] [Full Text] [Related]

  • 18. Lysine-specific demethylase 3A is important for autophagic occurrence.
    Kim J, Choi SA, Kim J, Kim H, Baek SH.
    Biochem Biophys Res Commun; 2020 May 21; 526(1):176-183. PubMed ID: 32201075
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia inducible factor-3α promotes osteosarcoma progression by activating KDM3A-mediated demethylation of SOX9.
    Li ZF, Meng DD, Liu YY, Bi FG, Tian K, Xu JZ, Sun JG, Gu CX, Li Y.
    Chem Biol Interact; 2022 Jan 05; 351():109759. PubMed ID: 34826399
    [Abstract] [Full Text] [Related]

  • 20. Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance.
    Zhang H, Fredericks T, Xiong G, Qi Y, Rychahou PG, Li JD, Pihlajaniemi T, Xu W, Xu R.
    Breast Cancer Res; 2018 Oct 01; 20(1):116. PubMed ID: 30285809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.